Literature DB >> 8068044

Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure.

Y Z Yang1, B Little, S R Meshnick.   

Abstract

Artemisinin and its derivatives are a promising new class of antimalarial agents containing an endoperoxide bridge. [14C]Artemisinin alkylated various proteins in vitro. Between 5 and 18% of added drug bound to hemoproteins such as catalase, cytochrome c, and hemoglobin. However, it did not react with heme-free globin. For catalase and hemoglobin, most of the drug reacted with the protein moiety rather than the heme. Artemisinin bound to human serum albumin (HSA) more efficiently at pH 8.6 than 7.4, more efficiently in Dulbecco's PBS than in Tris-HCl buffer, and better when HSA had been made fatty acid-free. Dihydroartemisinin also bound to HSA, whereas deoxyartemisinin, an inactive derivative, did not. There was no binding between DNA and artemisinin. These data provide insight into the mechanism of the reaction between artemisinin and proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8068044     DOI: 10.1016/0006-2952(94)90287-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

1.  Artemisinin and heme.

Authors:  Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.

Authors:  Matthias A Fügi; Sergio Wittlin; Yuxiang Dong; Jonathan L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

3.  Artemisone uptake in Plasmodium falciparum-infected erythrocytes.

Authors:  Sophie Pooley; Farrah A Fatih; Sanjeev Krishna; Michael Gerisch; Richard K Haynes; Ho-Ning Wong; Henry M Staines
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

Review 4.  Pharmacokinetics of artemisinin-type compounds.

Authors:  V Navaratnam; S M Mansor; N W Sit; J Grace; Q Li; P Olliaro
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

Review 5.  Recent advances in artemisinin production through heterologous expression.

Authors:  Patrick R Arsenault; Kristin K Wobbe; Pamela J Weathers
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice.

Authors:  Naglaa Mohamed El-Lakkany; Sayed Hassan Seif El-Din
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

7.  Prophylactic and therapeutic effects of a novel granulated formulation of Artemisia extract on broiler coccidiosis.

Authors:  Jahangir Kaboutari; Hossien Ali Arab; Kambiz Ebrahimi; Sadegh Rahbari
Journal:  Trop Anim Health Prod       Date:  2013-07-19       Impact factor: 1.559

8.  Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).

Authors:  Marcel Kaiser; Sergio Wittlin; Angela Nehrbass-Stuedli; Yuxiang Dong; Xiaofang Wang; Andrew Hemphill; Hugues Matile; Reto Brun; Jonathan L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  Stability of peroxide antimalarials in the presence of human hemoglobin.

Authors:  Darren J Creek; Eileen Ryan; William N Charman; Francis C K Chiu; Richard J Prankerd; Jonathan L Vennerstrom; Susan A Charman
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

10.  Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells.

Authors:  Kodihalli C Ravindra; Wanxing Eugene Ho; Chang Cheng; Luiz C Godoy; John S Wishnok; Choon Nam Ong; W S Fred Wong; Gerald N Wogan; Steven R Tannenbaum
Journal:  Chem Res Toxicol       Date:  2015-09-21       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.